+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronary Artery Bypass Grafts (CABG) - Global Strategic Business Report

  • PDF Icon

    Report

  • 176 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5028032
The global market for Coronary Artery Bypass Grafts (CABG) was estimated at US$170.2 Million in 2023, and is projected to reach US$233.0 Million by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Off-Pump CABG segment, which is expected to reach US$109.1 Million by 2030 with a CAGR of a 4.1%. The On-Pump CABG segment is also set to grow at 3.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $46.0 Million in 2023, and China, forecasted to grow at an impressive 4.2% CAGR to reach $36.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Coronary Artery Bypass Grafts (CABG) Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Coronary Artery Bypass Grafts (CABG) Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Coronary Artery Bypass Grafts (CABG) Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 41 Featured):

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Coronary Artery Bypass Grafts (CABG) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Coronary Artery Disease Propels Demand for CABG
  • Advancements in Minimally Invasive Surgery Techniques Expand Market Reach
  • Aging Population Globally Drives Need for Effective CABG Procedures
  • Rising Healthcare Expenditure and Insurance Coverage Bolster CABG Accessibility
  • Emerging Markets Witness Increased Adoption of Advanced Cardiac Care
  • Cardiac Rehabilitation Developments Post-CABG Surgery Support Patient Recovery
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Coronary Artery Bypass Grafts (CABG) Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • Table 5: World Recent Past, Current & Future Analysis for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Off-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for On-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Minimally Invasive Direct by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Saphenous Vein Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Internal Thoracic Artery Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
JAPAN
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
CHINA
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
EUROPE
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
FRANCE
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
GERMANY
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 81: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 82: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 84: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 85: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 87: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 88: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 90: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 91: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
  • Table 95: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife

Table Information